
### [MONDO:0005124](http://purl.obolibrary.org/obo/MONDO_0005124)
**Label:** leprosy

**Subclasses:** [MONDO:0005127](http://purl.obolibrary.org/obo/MONDO_0005127) (lepromatous leprosy), [MONDO:0009518](http://purl.obolibrary.org/obo/MONDO_0009518) (leprosy, susceptibility to, 3), [MONDO:0005125](http://purl.obolibrary.org/obo/MONDO_0005125) (borderline leprosy), [MONDO:0013257](http://purl.obolibrary.org/obo/MONDO_0013257) (LPRS6), [MONDO:0005126](http://purl.obolibrary.org/obo/MONDO_0005126) (tuberculoid leprosy), [MONDO:0011860](http://purl.obolibrary.org/obo/MONDO_0011860) (LPRS2), [MONDO:0013185](http://purl.obolibrary.org/obo/MONDO_0013185) (leprosy, susceptibility to, 5), [MONDO:0012595](http://purl.obolibrary.org/obo/MONDO_0012595) (leprosy, susceptibility to, 4), [MONDO:0012358](http://purl.obolibrary.org/obo/MONDO_0012358) (LPRS1), [MONDO:0001391](http://purl.obolibrary.org/obo/MONDO_0001391) (indeterminate leprosy), 

**Mapped go classes:** [GO:0006120](http://purl.obolibrary.org/obo/GO_0006120) (mitochondrial electron transport, NADH to ubiquinone), [GO:0007250](http://purl.obolibrary.org/obo/GO_0007250) (activation of NF-kappaB-inducing kinase activity), [GO:0032493](http://purl.obolibrary.org/obo/GO_0032493) (response to bacterial lipoprotein), [GO:0099073](http://purl.obolibrary.org/obo/GO_0099073) (mitochondrion-derived vesicle), [GO:0042495](http://purl.obolibrary.org/obo/GO_0042495) (detection of triacyl bacterial lipopeptide), [GO:0042497](http://purl.obolibrary.org/obo/GO_0042497) (triacyl lipopeptide binding), [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus), [GO:0042535](http://purl.obolibrary.org/obo/GO_0042535) (positive regulation of tumor necrosis factor biosynthetic process), [GO:0006954](http://purl.obolibrary.org/obo/GO_0006954) (inflammatory response), [GO:0002237](http://purl.obolibrary.org/obo/GO_0002237) (response to molecule of bacterial origin), [GO:0002755](http://purl.obolibrary.org/obo/GO_0002755) (MyD88-dependent toll-like receptor signaling pathway), [GO:0006955](http://purl.obolibrary.org/obo/GO_0006955) (immune response), [GO:0002876](http://purl.obolibrary.org/obo/GO_0002876) (positive regulation of chronic inflammatory response to antigenic stimulus), [GO:0046982](http://purl.obolibrary.org/obo/GO_0046982) (protein heterodimerization activity), [GO:0060729](http://purl.obolibrary.org/obo/GO_0060729) (intestinal epithelial structure maintenance), [GO:0006914](http://purl.obolibrary.org/obo/GO_0006914) (autophagy), [GO:0006959](http://purl.obolibrary.org/obo/GO_0006959) (humoral immune response), [GO:0032729](http://purl.obolibrary.org/obo/GO_0032729) (positive regulation of interferon-gamma production), [GO:0005829](http://purl.obolibrary.org/obo/GO_0005829) (cytosol), [GO:0050830](http://purl.obolibrary.org/obo/GO_0050830) (defense response to Gram-positive bacterium), [GO:0035354](http://purl.obolibrary.org/obo/GO_0035354) (Toll-like receptor 1-Toll-like receptor 2 protein complex), [GO:0071727](http://purl.obolibrary.org/obo/GO_0071727) (cellular response to triacyl bacterial lipopeptide), [GO:0050729](http://purl.obolibrary.org/obo/GO_0050729) (positive regulation of inflammatory response), [GO:0045335](http://purl.obolibrary.org/obo/GO_0045335) (phagocytic vesicle), [GO:0005164](http://purl.obolibrary.org/obo/GO_0005164) (tumor necrosis factor receptor binding), [GO:0042981](http://purl.obolibrary.org/obo/GO_0042981) (regulation of apoptotic process), [GO:0045410](http://purl.obolibrary.org/obo/GO_0045410) (positive regulation of interleukin-6 biosynthetic process), [GO:0004872](http://purl.obolibrary.org/obo/GO_0004872) (receptor activity), [GO:0002253](http://purl.obolibrary.org/obo/GO_0002253) (activation of immune response), [GO:0005125](http://purl.obolibrary.org/obo/GO_0005125) (cytokine activity), [GO:0042742](http://purl.obolibrary.org/obo/GO_0042742) (defense response to bacterium), [GO:0002376](http://purl.obolibrary.org/obo/GO_0002376) (immune system process), [GO:0042787](http://purl.obolibrary.org/obo/GO_0042787) (protein ubiquitination involved in ubiquitin-dependent protein catabolic process), [GO:0005886](http://purl.obolibrary.org/obo/GO_0005886) (plasma membrane), [GO:0005634](http://purl.obolibrary.org/obo/GO_0005634) (nucleus), [GO:0031624](http://purl.obolibrary.org/obo/GO_0031624) (ubiquitin conjugating enzyme binding), [GO:0005515](http://purl.obolibrary.org/obo/GO_0005515) (protein binding), [GO:0000151](http://purl.obolibrary.org/obo/GO_0000151) (ubiquitin ligase complex), [GO:0046872](http://purl.obolibrary.org/obo/GO_0046872) (metal ion binding), [GO:0044130](http://purl.obolibrary.org/obo/GO_0044130) (negative regulation of growth of symbiont in host), [GO:0002925](http://purl.obolibrary.org/obo/GO_0002925) (positive regulation of humoral immune response mediated by circulating immunoglobulin), [GO:0034137](http://purl.obolibrary.org/obo/GO_0034137) (positive regulation of toll-like receptor 2 signaling pathway), [GO:0031226](http://purl.obolibrary.org/obo/GO_0031226) (intrinsic component of plasma membrane), [GO:0032436](http://purl.obolibrary.org/obo/GO_0032436) (positive regulation of proteasomal ubiquitin-dependent protein catabolic process), [GO:2000484](http://purl.obolibrary.org/obo/GO_2000484) (positive regulation of interleukin-8 secretion), [GO:0071723](http://purl.obolibrary.org/obo/GO_0071723) (lipopeptide binding), [GO:0016567](http://purl.obolibrary.org/obo/GO_0016567) (protein ubiquitination), [GO:0034130](http://purl.obolibrary.org/obo/GO_0034130) (toll-like receptor 1 signaling pathway), [GO:0008283](http://purl.obolibrary.org/obo/GO_0008283) (cell proliferation), [GO:0061630](http://purl.obolibrary.org/obo/GO_0061630) (ubiquitin protein ligase activity), [GO:0035663](http://purl.obolibrary.org/obo/GO_0035663) (Toll-like receptor 2 binding), [GO:0034134](http://purl.obolibrary.org/obo/GO_0034134) (toll-like receptor 2 signaling pathway), [GO:0008284](http://purl.obolibrary.org/obo/GO_0008284) (positive regulation of cell proliferation), [GO:0048535](http://purl.obolibrary.org/obo/GO_0048535) (lymph node development), [GO:0005576](http://purl.obolibrary.org/obo/GO_0005576) (extracellular region), [GO:0009615](http://purl.obolibrary.org/obo/GO_0009615) (response to virus), [GO:0042116](http://purl.obolibrary.org/obo/GO_0042116) (macrophage activation), [GO:0006979](http://purl.obolibrary.org/obo/GO_0006979) (response to oxidative stress), [GO:0005887](http://purl.obolibrary.org/obo/GO_0005887) (integral component of plasma membrane), [GO:0048147](http://purl.obolibrary.org/obo/GO_0048147) (negative regulation of fibroblast proliferation), [GO:0046685](http://purl.obolibrary.org/obo/GO_0046685) (response to arsenic-containing substance), [GO:0001889](http://purl.obolibrary.org/obo/GO_0001889) (liver development), [GO:0043330](http://purl.obolibrary.org/obo/GO_0043330) (response to exogenous dsRNA), [GO:0031410](http://purl.obolibrary.org/obo/GO_0031410) (cytoplasmic vesicle), [GO:0031099](http://purl.obolibrary.org/obo/GO_0031099) (regeneration), [GO:0071797](http://purl.obolibrary.org/obo/GO_0071797) (LUBAC complex), [GO:0051865](http://purl.obolibrary.org/obo/GO_0051865) (protein autoubiquitination), [GO:0009266](http://purl.obolibrary.org/obo/GO_0009266) (response to temperature stimulus), [GO:0007165](http://purl.obolibrary.org/obo/GO_0007165) (signal transduction), [GO:0034166](http://purl.obolibrary.org/obo/GO_0034166) (toll-like receptor 10 signaling pathway), [GO:0000209](http://purl.obolibrary.org/obo/GO_0000209) (protein polyubiquitination), [GO:0050707](http://purl.obolibrary.org/obo/GO_0050707) (regulation of cytokine secretion), [GO:0060252](http://purl.obolibrary.org/obo/GO_0060252) (positive regulation of glial cell proliferation), [GO:0006952](http://purl.obolibrary.org/obo/GO_0006952) (defense response), [GO:0009987](http://purl.obolibrary.org/obo/GO_0009987) (cellular process), [GO:0002224](http://purl.obolibrary.org/obo/GO_0002224) (toll-like receptor signaling pathway), [GO:0004842](http://purl.obolibrary.org/obo/GO_0004842) (ubiquitin-protein transferase activity), [GO:0001774](http://purl.obolibrary.org/obo/GO_0001774) (microglial cell activation), [GO:0001775](http://purl.obolibrary.org/obo/GO_0001775) (cell activation), [GO:0009617](http://purl.obolibrary.org/obo/GO_0009617) (response to bacterium), [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space), [GO:0004888](http://purl.obolibrary.org/obo/GO_0004888) (transmembrane signaling receptor activity), [GO:0005737](http://purl.obolibrary.org/obo/GO_0005737) (cytoplasm), [GO:0045087](http://purl.obolibrary.org/obo/GO_0045087) (innate immune response), [GO:0016020](http://purl.obolibrary.org/obo/GO_0016020) (membrane), [GO:0005739](http://purl.obolibrary.org/obo/GO_0005739) (mitochondrion), [GO:0045121](http://purl.obolibrary.org/obo/GO_0045121) (membrane raft), [GO:0043065](http://purl.obolibrary.org/obo/GO_0043065) (positive regulation of apoptotic process), [GO:0016021](http://purl.obolibrary.org/obo/GO_0016021) (integral component of membrane), [GO:0032496](http://purl.obolibrary.org/obo/GO_0032496) (response to lipopolysaccharide), [GO:0016740](http://purl.obolibrary.org/obo/GO_0016740) (transferase activity), [GO:0106003](http://purl.obolibrary.org/obo/GO_0106003) (amyloid-beta complex), 

**Class expressions from DL-Learner:**

- [GO:0071725](http://purl.obolibrary.org/obo/GO_0071725) (response to triacyl bacterial lipopeptide) 53.45%
- Thing 53.44%
- [GO:0106003](http://purl.obolibrary.org/obo/GO_0106003) (amyloid-beta complex) 51.72%
- [GO:0099073](http://purl.obolibrary.org/obo/GO_0099073) (mitochondrion-derived vesicle) 51.72%
- [GO:0071797](http://purl.obolibrary.org/obo/GO_0071797) (LUBAC complex) 51.72%
- [GO:0071727](http://purl.obolibrary.org/obo/GO_0071727) (cellular response to triacyl bacterial lipopeptide) 51.72%
- [GO:0070340](http://purl.obolibrary.org/obo/GO_0070340) (detection of bacterial lipopeptide) 51.72%
- [GO:0050830](http://purl.obolibrary.org/obo/GO_0050830) (defense response to Gram-positive bacterium) 51.72%
- [GO:0042495](http://purl.obolibrary.org/obo/GO_0042495) (detection of triacyl bacterial lipopeptide) 51.72%
- [GO:0042494](http://purl.obolibrary.org/obo/GO_0042494) (detection of bacterial lipoprotein) 51.72%
- [GO:0035354](http://purl.obolibrary.org/obo/GO_0035354) (Toll-like receptor 1-Toll-like receptor 2 protein complex) 51.72%
- [GO:0034166](http://purl.obolibrary.org/obo/GO_0034166) (toll-like receptor 10 signaling pathway) 51.72%
- [GO:0034130](http://purl.obolibrary.org/obo/GO_0034130) (toll-like receptor 1 signaling pathway) 51.72%
- [GO:0005794](http://purl.obolibrary.org/obo/GO_0005794) (Golgi apparatus) 51.72%
- [GO:0005615](http://purl.obolibrary.org/obo/GO_0005615) (extracellular space) 51.72%


